Kailera Therapeutics Shares (Basic) increased by 2160600.0% to 21.6K in Q1 2026 compared to the prior quarter.
Changes reflect share buybacks (decrease) or equity issuance (increase), which impact the per-share earnings calculation.
The average number of common shares outstanding during the reporting period, calculated by weighting the number of share...
Standard metric for all public companies; reflects capital structure and share repurchase activity.
weighted_shares_basic| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | 1 | 21.6K |
| QoQ Change | — | >999% |
| YoY Change | — | >999% |